Illustration: Tiffany Herring/Axios
Cencora plans to acquire the majority of OneOncology's outstanding equity it does not own, including shares from TPG, for approximately $5 billion.
Why it matters: The deal values cancer practice network OneOncology at approximately $7.4 billion.
